Chinese media relayed a case this week in which an HPV test reportedly came back positive for 18 subtypes in one patient, 10 of them high-risk types, and the physician quoted in the headline calls the combination extremely rare and the long-term cancer risk significantly elevated [1]. A count like 18 reads like a severity score. Published guidance describes it as something narrower, a list of virus types a laboratory found. The number counts what the test detected. It does not measure danger. What decides the next step is which types on the report carry the high-risk marking, what the cell test shows, and what follow-up a provider schedules [2].
The case rests on a single relayed headline (Tencent News carrying a 潮新闻 report, dated November 11, with no English-language coverage of the case so far) [1]. The reader's moves stay the same regardless of how many types a report lists. Look at which types are marked high-risk, check what the Pap result says, and keep the follow-up that has been scheduled.
What the HPV test measures
The relayed report concerns the HPV test, and it is worth separating that from the test most people know. The HPV test looks for the virus that can cause cell changes on the cervix; the Pap test looks for precancers, cell changes that might become cervical cancer if they are not treated appropriately [2]. Both are office procedures that collect cells from the cervix and send them to a laboratory [2]. HPV itself is a group of more than 200 related viruses [3]; the relayed report says a single patient's test detected 18 types [1]. The specific HPV type, the CDC screening page says, may be identified to determine the next step [2]. The types on the report fall into two categories, and the two categories lead to different follow-up.
The two categories behind the type list
NIH's MedlinePlus health topic sorts the sexually transmitted types into two categories, low-risk HPV and high-risk HPV [3]. Low-risk types can cause warts on or around the genitals, anus, mouth, or throat [3]. The high-risk types are the cancer-linked ones. MedlinePlus lists the cancers high-risk HPV can cause, cervical, anal, oropharyngeal (throat), vulvar, vaginal, and penile [3], and the National Cancer Institute's overview page lists the same cancer sites in its image caption [4]. Certain low-risk types announce themselves as warts. The high-risk types have no symptoms; a high-risk infection can stay at the cervix for many years and cause cell changes, which may produce symptoms, and if those changes are not screened for and treated they may get worse over time and become cancer [3]. HPV infections are very common, and usually the immune system controls them so they go away on their own without causing health problems [3]. The danger question turns on the high-risk marking next to each type on the report, and on whether a high-risk infection persists, which is the situation routine screening exists to catch.
What moves the next step
Nearly all cervical cancers are caused by a long-lasting infection with a high-risk type, and screening prevents cancer by finding changes that might happen before cancer, the changes called precancer [3]. Cervical precancer, as the CDC defines it, means cells that look abnormal but are not yet cancerous; it usually causes no pain or symptoms and is found with a Pap test [2]. The provider acts on what the Pap shows. An abnormal Pap usually does not mean cervical cancer. Most minor (low-grade) changes go back to normal on their own, while more serious (high-grade) changes can turn into cancer if they are not removed [2]. When results need a closer look, the published pathway runs through colposcopy, an examination of the cervix, vagina, and vulva with a lighted magnifying device; if the provider sees a problem, they may take a tissue sample for testing, a biopsy [5]. Results can take as long as three weeks, and if something might not be normal, the doctor will contact the patient and work out how best to follow up [2]. An HPV infection itself cannot be treated; what gets treated, when needed, are warts or cell changes, and the CDC notes that in most cases treatment prevents cervical cancer from developing [2][3]. Hypothetical example, labeled as such. Two people receive positive HPV results and their reports differ. One lists low-risk types with a normal Pap; the other lists a high-risk type with an abnormal Pap. The published pathway sends the second report toward colposcopy; for the first, the published advice is to talk with a provider about whether other tests are needed and how often to be checked [3].
The screening ages, labeled as US guidance
All ages below come from CDC policy and apply to the United States. Pap tests start at age 21, and a normal result typically means waiting three years for the next one [2]. From 30 to 65, the options are an HPV test alone every five years, HPV together with a Pap test every five years, or a Pap test alone every three [2]. Past 65, screening can stop under conditions that include at least three normal Pap tests or two negative HPV tests in the past 10 years and no history of cervical precancer [2]. For readers in the US worried about cost, CDC funds free or low-cost cervical screening through the National Breast and Cervical Cancer Early Detection Program [2]. Vaccines protect against several HPV types and provide the most protection before exposure to the virus; someone over 26 who has not been vaccinated can ask a provider about the possible benefits [3]. The reported patient is 18 [1], an age outside every US screening band. Screening schedules differ by country. The schedule that governs any reader is the one their own health system publishes, and the questions to bring to it are types, cells, and follow-up.
What the reader takes from the report
The physician quoted in the relayed headline called this combination extremely rare and the long-term risk significantly elevated [1]. That judgment belongs to one reported case and stays with it. For the reader whose own report came back normal, the CDC page carries the reassurance that matters, that the chance of getting cervical cancer in the next few years is very low, with screening continuing on the usual schedule [2]. The headline's 18 counts types found. The columns beside the number, the risk marking and the cell result, decide what happens next, and the follow-up appointment turns them into a plan.